CKS2 and central nervous system cancer: Previous oligonucleotide microarray analysis also reported that CKS2mRNA was aberrantly elevated in glioma tissues; besides, CKS2 has been described as upregulation in high‐grade gliomas compared to the low‐grade glioma,13 however, whether CKS2 overexpression could stimulate glioma cell motility remained to be verified.